Cerebras upsizes IPO to $4.8B with OpenAI taking 3% stake

The most consequential detail in the Cerebras IPO is not the valuation. It is the mechanism by which OpenAI is set to walk away with roughly a 3% post-IPO stake without writing an equity check. OpenAI committed to spend more than $20 billion on Cerebras chips and lent the company $1 billion in January 2026 at 6% interest, secured by warrants for more than 33 million shares that vest as it consumes 2 gigawatts of Cerebras compute ^[1]. The structure converts a procurement promise into ownership: OpenAI gets paid in equity for the act of being a customer.

The arithmetic compounds across OpenAI's portfolio of supply-chain bets. The Information reports OpenAI is sitting on roughly $2.6 billion in combined Cerebras and CoreWeave stock obtained the same way, by pledging future spending on chips and cloud capacity ^[2]. Sam Altman personally appeared in a Cerebras-produced promotional video for the IPO and is named in the S-1 as a Cerebras stockholder ^[1], and OpenAI President Greg Brockman has separately disclosed personal stakes in both Cerebras and CoreWeave under OpenAI's conflict-of-interest policy ^[3]. The pattern reframes how to read OpenAI's losses: every dollar of compute it 'spends' may also be a dollar that builds an off-balance-sheet equity portfolio in its own suppliers.

Cerebras's 2026 victory lap is almost unrecognizable from the disaster of late 2024. The company filed its first S-1 in September 2024 with Citigroup as lead underwriter ^[4], only to see the IPO derailed within weeks when the Committee on Foreign Investment in the United States opened a review of G42, the Abu Dhabi AI firm whose minority stake had also made it Cerebras's single largest customer, accounting for roughly 87% of first-half 2024 revenue ^[5]. The concern was straightforward: a chip company whose biggest revenue source and largest outside investor was the same Gulf entity with documented China linkages was not a clean fit for a US-listed AI national champion.

The path back ran through three changes. G42's holdings were restructured into non-voting shares, which Cerebras announced in March 2025 alongside CFIUS clearance ^[6]. Customer concentration was diluted by signing OpenAI to a multi-year deal worth more than $10 billion in December 2025 ^[1], then layering the AWS partnership on top in March 2026 ^[7]. And the bankers changed too: Morgan Stanley replaced Citigroup as lead underwriter on the refiled S-1 ^[4]. By the time Cerebras filed publicly in April 2026, the company looked less like a Gulf-dependent custom-silicon shop and more like a US hyperscaler-aligned chip designer with a household-name anchor customer.

At $160 per share, Cerebras trades at roughly 96 times trailing sales, a multiple Motley Fool analyst Danny Vena described as 'lofty' for an unproven company ^[8]. The bull case, articulated most aggressively by Hedgeye's Felix Wang with a $188 target nearly 57% above the original midpoint, leans on Cerebras's wafer-scale architecture being structurally suited to inference, the workload analysts increasingly expect to dominate AI compute spend ^[9]. PitchBook's Dimitri Zabelin reinforces the thesis, observing that 'the AI market itself shifted in Cerebras' favor' as agentic and real-time applications push latency to the front of the buying criteria ^[10]. Demand validates the narrative on paper: the book was reportedly more than 20 times oversubscribed, with pre-roadshow indications of interest topping $10 billion ^[11].

The bear case is harder to wave away. Morningstar's Brian Colello points to head-to-head competition with Nvidia and its newly acquired Groq inference unit as the dominant risk new investors are underpricing ^[10]. The valuation gap is the real tell: a 96x multiple towers over established profitable peers like Nvidia and AMD, and Cerebras at $160 is pricing in not just inference dominance but the kind of customer concentration that the CFIUS process was supposed to have cured, with OpenAI's $20B+ chip commitment and the AWS distribution deal as the two named pillars of contracted demand. Retail finance communities are explicitly pricing this discount: the most upvoted r/stocks post on the deal concluded that 'the bankers have cooked it' and exited the trade. The IPO is a referendum on whether inference is a winner-take-most market and whether Cerebras, not Nvidia-Groq, takes it.

Cerebras's pitch is no longer that wafer-scale chips are a curiosity. It is that the AI workload mix has shifted under Nvidia's feet. Where training runs reward raw FLOPs across vast GPU clusters, inference, especially for agentic and real-time applications, rewards low latency and high memory bandwidth per query, which is the exact regime where a single-wafer design with on-chip memory has a structural advantage. AWS Vice President David Brown framed the bottleneck explicitly when the Cerebras collaboration launched in March 2026: 'Inference is where AI delivers real value to customers, but speed remains a critical bottleneck for demanding workloads like real-time coding assistance and interactive applications' ^[7]. The deal pairs Cerebras CS-3 systems with AWS Trainium and EFA networking, all surfaced to enterprise developers through Amazon Bedrock, giving Cerebras for the first time a hyperscale distribution channel rather than a direct-sales motion.

That distribution matters because Cerebras's commercial model has always been the choke point. Andrew Feldman's framing, that 'every enterprise around the world will be able to benefit from blisteringly fast inference,' is only credible if customers can procure CS-3 capacity the same way they procure H100s, through the cloud console they already use ^[12]. The flip side is that the IPO valuation embeds an assumption inference compute will not consolidate back to Nvidia. Nvidia spent more than $18 billion on R&D in fiscal 2026 and paid roughly $20 billion to acquire Groq in December 2025 explicitly to defend the inference flank ^[10]. Cerebras's $48.8 billion price tag is, in effect, the market betting that AWS-distributed wafer scale is a more durable answer than a Nvidia-owned inference roadmap. The first real datapoint arrives when CBRS opens for trading on May 14.